Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Astellas eyes cancer drugs to stabilize profit picture
Fierce Pharma
Wednesday, July 20, 2011 - 1:05pm
tags:
Astellas, cancer
Secret Scythe: Novartis Neglects to Mention 2,000 Layoffs
BNET Pharma
Wednesday, July 20, 2011 - 12:55pm
tags:
Novartis, layoffs
Oncothyreon: Possible Pharma Blockbuster
Seeking Alpha
Wednesday, July 20, 2011 - 12:53pm
tags:
Oncothyreon, Stimuvax, non-small cell lung cancer
Dynavax plunges 16% on mixed study results
Marketwatch
Wednesday, July 20, 2011 - 12:52pm
tags:
Dynavax, vaccines, hepatitis B, Heplisav
Abbott’s Freyman Says Humira Gained Market Share in Crohn’s, Psoriasis
Bloomberg
Wednesday, July 20, 2011 - 12:50pm
tags:
Crohn's Disease, psoriasis, Abbott Laboratories, Humira
J&J Special Committee: There Was No Wrongdoing
Pharmalot
Wednesday, July 20, 2011 - 12:50pm
tags:
JNJ
Icon’s Gray Says Pfizer Contracts to Normalize by End of 2012
Bloomberg
Wednesday, July 20, 2011 - 12:49pm
tags:
ICON, Pfizer
Amag-Allos: Worst Bio-Merger in History
TheStreet.com
Wednesday, July 20, 2011 - 11:43am
tags:
Allos, M&A, Amag Pharmaceuticals
Dr. Reddy's Q1 FY12 Financial Results
Yahoo
Wednesday, July 20, 2011 - 11:42am
tags:
earnings, Dr Reddy's
Biotechnology Bounces Back With 46% Rise in Venture Capital
Bloomberg
Wednesday, July 20, 2011 - 11:22am
tags:
venture capital, biotech
AAIC: High Dose of Bristol’s Avagacestat May Also Be Tied to Cognitive Problems
WSJ Online
Wednesday, July 20, 2011 - 11:17am
tags:
Avagacestat, Alzheimer's disease, Bristol-Myers Squibb
Icagen plunges on Pfizer takeover terms
Marketwatch
Wednesday, July 20, 2011 - 10:24am
tags:
M&A, Icagen, Pfizer
Abbott Labs net up 50%; year outlook
Marketwatch
Wednesday, July 20, 2011 - 10:23am
tags:
earnings, Abbott Laboratories
Merck and Roche Expand Agreement in Fight Against Chronic Hepatitis C
Yahoo
Wednesday, July 20, 2011 - 10:22am
tags:
Chronic Hepatitis C, Merck, Roche, Victrelis
J&J Alzheimer Drug Shows No New Alerts in Longer Trial
Bloomberg
Wednesday, July 20, 2011 - 10:20am
tags:
JNJ, Alzheimer's disease, bapineuzumab, Pfizer
7 Biotechs Near 52-Week Lows
Motley Fool
Tuesday, July 19, 2011 - 6:29pm
tags:
Amgen, Human Genome Sciences, Isis Pharmaceuticals, Enzon, Protalix BioTherapeutics, Geron, Savient
Forest FY Q1 profit tops expectations; sales rise
Reuters
Tuesday, July 19, 2011 - 6:17pm
tags:
earnings, Forest Labs
Dynavax Technologies: Heplisav Trial Results to Be Big Catalyst for Stock
Seeking Alpha
Tuesday, July 19, 2011 - 6:13pm
tags:
Heplisav, Dynavax, vaccines, hepatitis B
Bristol, AstraZeneca Rebuffed by FDA Panel on Diabetes Drug
Bloomberg
Tuesday, July 19, 2011 - 6:11pm
tags:
FDA, AstraZeneca, diabetes, Bristol-Myers Squibb, Dapagliflozin
Regulatory "sword of Damocles" dangles over two big AZ drugs
Fierce Biotech
Tuesday, July 19, 2011 - 1:14pm
tags:
AstraZeneca, FDA, Brilinta, blood thinners, Dapagliflozin, Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.